Literature DB >> 29754032

Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies.

Khary K Rigg1, Shannon M Monnat2, Melody N Chavez3.   

Abstract

Over the last two decades, opioid-related mortality rates have increased dramatically to become a serious public health concern in the United States. Opioid-related mortality has reached epidemic levels in certain rural areas of the U.S., such as Appalachia, New England, and the Mountain West, while remaining relatively low in others, such as the Delta South and Great Plains. Explanations for geographic variation in opioid mortality are unclear, contributing to ineffective policies and interventions. The goal of this article is to summarize the existing literature on the opioid epidemic in the rural U.S. to help guide intervention efforts. This paper 1) describes geographic heterogeneity in opioid-related mortality, with a focus on rural areas, 2) summarizes factors that likely contribute to this heterogeneity, and 3) discusses potential strategies for addressing the opioid epidemic in the hardest-hit rural communities. The information presented in this paper dispels the myth that the opioid epidemic is disproportionately rural, and demonstrates that the magnitude of the epidemic has varied considerably across different rural areas. This paper provides important insights for public health professionals, treatment practitioners, researchers, and policymakers as they work toward solutions that take into account the diversity of rural communities and the dynamic nature of the opioid epidemic.
Copyright © 2018 Elsevier B.V. All rights reserved.

Keywords:  Fentanyl; Harm reduction; Heroin; Opioid use disorders; Opioid-related mortality; Prevention; Rural; Treatment; Urban

Mesh:

Year:  2018        PMID: 29754032     DOI: 10.1016/j.drugpo.2018.04.011

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  68 in total

1.  Life Expectancy and Mortality Rates in the United States, 1959-2017.

Authors:  Steven H Woolf; Heidi Schoomaker
Journal:  JAMA       Date:  2019-11-26       Impact factor: 56.272

2.  Who receives naloxone from emergency medical services? Characteristics of calls and recent trends.

Authors:  Caroline Geiger; Rosanna Smart; Bradley D Stein
Journal:  Subst Abus       Date:  2019-07-30       Impact factor: 3.716

3.  The Depths of Despair Among US Adults Entering Midlife.

Authors:  Lauren Gaydosh; Robert A Hummer; Taylor W Hargrove; Carolyn T Halpern; Jon M Hussey; Eric A Whitsel; Nancy Dole; Kathleen Mullan Harris
Journal:  Am J Public Health       Date:  2019-05       Impact factor: 9.308

4.  The Contemporary American Drug Overdose Epidemic in International Perspective.

Authors:  Jessica Y Ho
Journal:  Popul Dev Rev       Date:  2019-02-20

5.  Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses.

Authors:  Julien Cobert; Paul M Lantos; Mark M Janko; David G A Williams; Karthik Raghunathan; Vijay Krishnamoorthy; Eric A JohnBull; Atilio Barbeito; Padma Gulur
Journal:  J Urban Health       Date:  2020-12       Impact factor: 3.671

6.  Bridging the Gap in Potentially Excess Deaths Between Rural and Urban Counties in the United States.

Authors:  Macarena C Garcia; Mark Faul; Nicole F Dowling; Cheryll C Thomas; Michael F Iademarco
Journal:  Public Health Rep       Date:  2020-01-22       Impact factor: 2.792

7.  Fentanyl exposure among patients seeking opioid treatment.

Authors:  Taylor A Ochalek; Maria A Parker; Stephen T Higgins; Stacey C Sigmon
Journal:  J Subst Abuse Treat       Date:  2018-10-17

8.  Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia.

Authors:  Braden K Linn; Gretchen E Ely; Michele Staton
Journal:  J Soc Work Pract Addict       Date:  2020-04-07

9.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

10.  Drivers of opioid use in Appalachian Pennsylvania: Cross-cutting social and community-level factors.

Authors:  Jessica R Thompson; Stephanie L Creasy; Christina F Mair; Jessica G Burke
Journal:  Int J Drug Policy       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.